Suchbegriffe: PLATELET AGGREGATION - DRUG EFFECTS , . Treffer: 65
Haidl, H; Schlagenhauf, A; Krebs, A; Plank, H; Wonisch, W; Fengler, V; Fiegl, A; Hörl, G; Koestenberger, M; Wagner, T; Tafeit, E; Cvirn, G; Hallström, S
The anticoagulant effects of ethyl pyruvate in whole blood samples.
PLoS One. 2020; 15(10):e0240541-e0240541
Doi: 10.1371/journal.pone.0240541
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Freynhofer, MK; Hein-Rothweiler, R; Haller, PM; Aradi, D; Dézsi, DA; Gross, L; Orban, M; Trenk, D; Geisler, T; Huczek, Z; Toth-Gayor, GG; Massberg, S; Huber, K; Sibbing, D
Diurnal Variability of On-Treatment Platelet Reactivity in Clopidogrel versus Prasugrel Treated Acute Coronary Syndrome Patients: A Pre-Specified TROPICAL-ACS Sub-Study.
Thromb Haemost. 2019; 119(4):660-667
Doi: 10.1055/s-0038-1677549
Web of Science
PubMed
FullText
FullText_MUG
Mahla, E; Metzler, H; Bornemann-Cimenti, H; Prueller, F; Raggam, RB; Pregartner, G; Berghold, A; Baumann, A; Goeroeg, C; Gurbel, PA
Platelet Inhibition and Bleeding in Patients Undergoing Non-Cardiac Surgery-The BIANCA Observational Study.
Thromb Haemost. 2018; 118(5):864-872
Doi: 10.1055/s-0038-1641153
Web of Science
PubMed
FullText
FullText_MUG
Enko, D; Mangge, H; Münch, A; Niedrist, T; Mahla, E; Metzler, H; Prüller, F
Pneumatic tube system transport does not alter platelet function in optical and whole blood aggregometry, prothrombin time, activated partial thromboplastin time, platelet count and fibrinogen in patients on anti-platelet drug therapy.
Biochem Med (Zagreb). 2017; 27(1):217-224
Doi: 10.11613/BM.2017.023
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Paar, M; Rossmann, C; Nusshold, C; Wagner, T; Schlagenhauf, A; Leschnik, B; Oettl, K; Koestenberger, M; Cvirn, G; Hallström, S
Anticoagulant action of low, physiologic, and high albumin levels in whole blood.
PLoS One. 2017; 12(8):e0182997-e0182997
Doi: 10.1371/journal.pone.0182997
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Prüller, F; Rosskopf, K; Mangge, H; Mahla, E; von Lewinski, D; Weiss, EC; Riegler, A; Enko, D
Implementation of buffy-coat-derived pooled platelet concentrates for internal quality control of light transmission aggregometry: a proof of concept study.
J Thromb Haemost. 2017; 15(12):2443-2450
Doi: 10.1111/jth.13870
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Olivier, CB; Weik, P; Meyer, M; Weber, S; Anto-Michel, N; Diehl, P; Zhou, Q; Geisen, U; Bode, C; Moser, M
TRAP-induced platelet aggregation is enhanced in cardiovascular patients receiving dabigatran.
Thromb Res. 2016; 138(2):63-68
Doi: 10.1016/j.thromres.2015.10.038
Web of Science
PubMed
FullText
FullText_MUG
Pasterk, L; Lemesch, S; Leber, B; Trieb, M; Curcic, S; Stadlbauer, V; Schuligoi, R; Schicho, R; Heinemann, A; Marsche, G
Oxidized plasma albumin promotes platelet-endothelial crosstalk and endothelial tissue factor expression.
Sci Rep. 2016; 6(3):22104-22104
Doi: 10.1038/srep22104
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Pasterk, L; Philipose, S; Eller, K; Marsche, G; Heinemann, A; Schuligoi, R
The EP3 Agonist Sulprostone Enhances Platelet Adhesion But Not Thrombus Formation Under Flow Conditions.
Pharmacology. 2015; 96(3-4):137-143
Doi: 10.1159/000437143
Web of Science
PubMed
FullText
FullText_MUG
Robier, C; Neubauer, M; Quehenberger, F; Stettin, M; Neumeister, P
Assessment of the response to acetylsalicylic acid in patients with myeloproliferative neoplasms by whole blood assays: a comparison of the PFA-100 with multiple electrode aggregometry.
Platelets. 2014; 25(8):608-611
Doi: 10.3109/09537104.2013.852661
Web of Science
PubMed
FullText
FullText_MUG
Kargl, J; Brown, AJ; Andersen, L; Dorn, G; Schicho, R; Waldhoer, M; Heinemann, A
A selective antagonist reveals a potential role of G protein-coupled receptor 55 in platelet and endothelial cell function.
J Pharmacol Exp Ther. 2013; 346(1):54-66
Doi: 10.1124/jpet.113.204180
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Robier, C; Stettin, M; Neubauer, M
Changes in response to antiaggregatory treatment in patients with myeloproliferative neoplasms: a sequential study using multiple electrode aggregometry.
Blood Coagul Fibrinolysis. 2013; 24(8): 869-873.
Doi: 10.1097/MBC.0b013e328364713a
Web of Science
PubMed
FullText
FullText_MUG
Tantry, US; Mahla, E; Gesheff, MG; Gurbel, PA
Importance of measurement of platelet reactivity to ADP in patients with coronary artery disease: an historical account.
Expert Rev Cardiovasc Ther. 2013; 11(11):1547-1556
Doi: 10.1586/14779072.2013.839382
PubMed
FullText
FullText_MUG
Philipose, S; Konya, V; Lazarevic, M; Pasterk, LM; Marsche, G; Frank, S; Peskar, BA; Heinemann, A; Schuligoi, R
Laropiprant Attenuates EP3 and TP Prostanoid Receptor-Mediated Thrombus Formation.
PLoS One. 2012; 7(8):e40222-e40222
Doi: 10.1371/journal.pone.0040222
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Prüller, F; Drexler, C; Archan, S; Macher, S; Raggam, RB; Mahla, E
Low platelet reactivity is recovered by transfusion of stored platelets: a healthy volunteer in vivo study.
J Thromb Haemost. 2011; 9(8):1670-1673
Doi: 10.1111/j.1538-7836.2011.04392.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Robier, C; Strohmeier, L; Quehenberger, F; Neubauer, M; Stettin, M; Rainer, F
The effect of intravenous high-dose methylprednisolone on platelet reactivity assessed with multiple electrode aggregometry.
THROMB HAEMOSTASIS. 2011; 105(6): 1110-1111.
Doi: 10.1160/TH11-01-0008
Web of Science
PubMed
FullText
FullText_MUG
Antonino, MJ; Coppolecchia, R; Mahla, E; Bliden, KP; Tantry, US; Gurbel, PA
Antiplatelet effects of aspirin with phytosterols: comparison with non-enteric coated aspirin alone.
Thromb Res. 2010; 126(5):384-385
Doi: 10.1016/j.thromres.2009.05.003
Web of Science
PubMed
FullText
FullText_MUG
Philipose, S; Konya, V; Sreckovic, I; Marsche, G; Lippe, IT; Peskar, BA; Heinemann, A; Schuligoi, R
The Prostaglandin E2 Receptor EP4 Is Expressed by Human Platelets and Potently Inhibits Platelet Aggregation and Thrombus Formation.
Arterioscler Thromb Vasc Biol. 2010; 30(12): 2416-2423.
Doi: 10.1161/ATVBAHA.110.216374
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Robier, C; Neubauer, M; Sternad, H; Quehenberger, F; Rainer, F; Neumeister, P
Evaluation of platelet function and pharmacological platelet inhibition in patients with myeloproliferative disorders using multiple electrode aggregometry.
THROMB RES. 2010; 126(3): 232-237.
Doi: 10.1016/j.thromres.2010.06.014
Web of Science
PubMed
FullText
FullText_MUG
Robier, C; Neubauer, M; Sternad, H; Rainer, F
Hirudin-induced pseudothrombocytopenia in a patient with EDTA-dependent platelet aggregation: report of a new laboratory artefact.
Int J Lab Hematol. 2010; 32(4): 452-453.
Doi: 10.1111/j.1751-553X.2009.01200.x
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Schlagenhauf, A; Schweintzger, S; Birner-Gruenberger, R; Leschnik, B; Muntean, W
Newborn platelets: lower levels of protease-activated receptors cause hypoaggregability to thrombin.
Platelets. 2010; 21(8):641-647
Doi: 10.3109/09537104.2010.504869
Web of Science
PubMed
FullText
FullText_MUG
Antonino, MJ; Mahla, E; Bliden, KP; Tantry, US; Gurbel, PA
Effect of long-term clopidogrel treatment on platelet function and inflammation in patients undergoing coronary arterial stenting.
Am J Cardiol. 2009; 103(11): 1546-1550.
Doi: 10.1016/j.amjcard.2009.01.367
Web of Science
PubMed
FullText
FullText_MUG
Gurbel, PA; Bliden, KP; Saucedo, JF; Suarez, TA; DiChiara, J; Antonino, MJ; Mahla, E; Singla, A; Herzog, WR; Bassi, AK; Hennebry, TA; Gesheff, TB; Tantry, US
Bivalirudin and clopidogrel with and without eptifibatide for elective stenting: effects on platelet function, thrombelastographic indexes, and their relation to periprocedural infarction results of the CLEAR PLATELETS-2 (Clopidogrel with Eptifibatide to Arrest the Reactivity of Platelets) study.
J Am Coll Cardiol. 2009; 53(8): 648-657.
Doi: 10.1016/j.jacc.2008.10.045
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Gurbel, PA; Mahla, E; Antonino, MJ; Tantry, US
Response variability and the role of platelet function testing.
J Invasive Cardiol. 2009; 21(4): 172-178.
[OPEN ACCESS]
Web of Science
PubMed
Mahla, E; Antonino, MJ; Tantry, US; Gurbel, PA
Point-of-care platelet function analysis ready for prime time?
J Am Coll Cardiol. 2009; 53(10): 857-859.
Doi: 10.1016/j.jacc.2008.11.033
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Tantry, US; Mahla, E; Gurbel, PA
Aspirin resistance.
Prog Cardiovasc Dis. 2009; 52(2): 141-152.
Doi: 10.1016/j.pcad.2009.05.001
Web of Science
PubMed
FullText
FullText_MUG
von Lewinski, F; Riggert, J; Paulus, W
Towards a rationale of platelet aggregation monitoring in stroke prophylaxis?
J Stroke Cerebrovasc Dis. 2009; 18(2):111-115
Doi: 10.1016/j.jstrokecerebrovasdis.2008.09.010
Web of Science
PubMed
FullText
FullText_MUG
Cvirn, G; Gallistl, S; Koestenberger, M; Kutschera, J; Ferstl, U; Kellner, J; Jurgens, G; Gries, A
Effects of beta2-glycoprotein-I on platelet aggregation in cord versus adult whole blood.
PLATELETS. 2007; 18(1): 24-28.
Doi: 10.1080/09537100600800529
Web of Science
PubMed
FullText
FullText_MUG
Schuligoi, R; Schmidt, R; Geisslinger, G; Kollroser, M; Peskar, BA; Heinemann, A
PGD2 metabolism in plasma: kinetics and relationship with bioactivity on DP1 and CRTH2 receptors.
Biochem Pharmacol. 2007; 74(1): 107-117.
Doi: 10.1016/j.bcp.2007.03.023
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Koestenberger, M; Gallistl, S; Cvirn, G; Roschitz, B; Rehak, T; Leschnik, B; Muntean, W
Combined effects of melagatran and eptifibatide on platelet aggregation inhibition but not thrombin generation inhibition.
BLOOD COAGULAT FIBRINOL. 2004; 15(2): 131-137.
Doi: 10.1097%2F00001721-200403000-00004
Web of Science
PubMed
FullText
FullText_MUG
Köstenberger, M; Gallistl, S; Cvirn, G; Muntean, W
A laboratory method for parallel determination of platelet aggregation and thrombin generation.
Clin Lab. 2004; 50(1-2): 41-48.
PubMed
Koestenberger, M; Gallistl, S; Cvirn, G; Roschitz, B; Petritsch, M; Leschnik, B; Muntean, W
Combined effects of eptifibatide and anticoagulants: differences between LMWH and UH or rH in thrombin generation inhibition but not in platelet aggregation inhibition.
Thromb Haemost. 2002; 88(6):1012-1019
Doi: 10.1267/th02121012
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Roller, RE; Dorr, A; Ulrich, S; Pilger, E
Effect of aspirin treatment in patients with peripheral arterial disease monitored with the platelet function analyzer PFA-100.
Blood Coagul Fibrinolysis. 2002; 13(4):277-281
Doi: 10.1097/00001721-200206000-00001
Web of Science
PubMed
FullText
FullText_MUG
Marumo, M; Suehiro, A; Kakishita, E; Groschner, K; Wakabayashi, I
Extracellular pH affects platelet aggregation associated with modulation of store-operated Ca(2+) entry.
Thromb Res. 2001; 104(5):353-360
Doi: 10.1016/S0049-3848(01)00374-7
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Koestenberger, M; Gallistl, S; Cvirn, G; Roschitz, B; Muntean, W
Effects of the glycoprotein IIb/IIIa receptor antagonist c7E3 Fab and anticoagulants on platelet aggregation and thrombin potential under high coagulant challenge in vitro.
Blood Coagul Fibrinolysis. 2000; 11(5):425-432
Doi: 10.1097%2F00001721-200007000-00005
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Bonatti, J; Dichtl, W; Dworzak, EA; Antretter, H; Unger, F; Puschendorf, B; Dapunt, OE
Stimulated prostacyclin release by conduits used for coronary artery bypass grafting.
Thorac Cardiovasc Surg. 1998; 46(2):59-62
Doi: 10.1055/s-2007-1010190
Web of Science
PubMed
FullText
FullText_MUG
Sinzinger, H; Neumann, I; O'Grady, J; Rogatti, W; Peskar, BA
PGE1-induced arterial thromboresistance is a vascular property as identified by cross-perfusion technique.
Prostaglandins Leukot Essent Fatty Acids. 1997; 56(4):325-330
Doi: 10.1016/S0952-3278(97)90577-9
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Pallapies, D; Muhs, A; Bertram, L; Rohleder, G; Nagyiványi, P; Peskar, BA
Effects of single oral doses of lysine clonixinate and acetylsalicylic acid on platelet functions in man.
Eur J Clin Pharmacol. 1996; 49(5):351-354
Doi: 10.1007%2Fs002280050030
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Gallistl, S; Muntean, W; Leis, HJ
Effects of heparin and hirudin on thrombin generation and platelet aggregation after intrinsic activation of platelet rich plasma.
Thromb Haemost. 1995; 74(4):1163-1168
Doi: 10.1055/s-0038-1649897
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Haas, A; Trummer, G; Eckhardt, M; Schmut, O; Uyguner, I; Pfeiffer, KP
Effect of calcium dobesilate on progression of diabetic retinopathy
Klin Monatsbl Augenheilkd. 1995; 207(1):17-21
Doi: 10.1055/s-2008-1035343
Web of Science
PubMed
FullText
FullText_MUG
Herrmann, W; Biermann, J; Kostner, GM
Comparison of effects of N-3 to N-6 fatty acids on serum level of lipoprotein(a) in patients with coronary artery disease.
Am J Cardiol. 1995; 76(7):459-462
Doi: 10.1016%2FS0002-9149%2899%2980130-1
Web of Science
PubMed
FullText
FullText_MUG
Malle, E; Ibovnik, A; Leis, HJ; Kostner, GM; Verhallen, PF; Sattler, W
Lysine modification of LDL or lipoprotein(a) by 4-hydroxynonenal or malondialdehyde decreases platelet serotonin secretion without affecting platelet aggregability and eicosanoid formation.
Arterioscler Thromb Vasc Biol. 1995; 15(3):377-384
Doi: 10.1161/01.ATV.15.3.377
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Pallapies, D; Peskar, BA; Peskar, BM
Interaction of 5-aminosalicylic acid with nitric oxide on rat aortic strips and human platelets.
Eur J Pharmacol. 1995; 282(1-3):145-149
Doi: 10.1016%2F0014-2999%2895%2900305-5
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Pallapies, D; Peskar, BA; Brune, K; Geisslinger, G
Effects on platelet functions and pharmacokinetics of azapropazone and ketorolac tromethamine given as single parenteral doses.
Br J Clin Pharmacol. 1994; 37(4):335-339
Doi: 10.1111/j.1365-2125.1994.tb04286.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Pallapies, D; Peskar, BA; Brune, K; Zeilhofer, HU
Modulation of nitric oxide effects by flurbiprofen enantiomers and nefopam and its relation to antinociception.
Eur J Pharmacol. 1994; 271(2-3):335-340
Doi: 10.1016/0014-2999(94)90791-9
Web of Science
PubMed
FullText
FullText_MUG
Lippe, IT; Sametz, W; Sabin, K; Holzer, P
Inhibitory role of capsaicin-sensitive afferent neurons and nitric oxide in hemostasis.
Am J Physiol. 1993; 265(6 Pt 2):H1864-H1868
Doi: 10.1152/ajpheart.1993.265.6.H1864
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Pallapies, D; Peskar, BA
Effect of prostaglandin (PG) E1 and its initial metabolites on neutrophil-induced inhibition of human platelet aggregation.
Thromb Res. 1993; 71(3):217-225
Doi: 10.1016/0049-3848(93)90096-7
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Pallapies, D; Peskar, BA
13,14-Dihydro-prostaglandin E1 in atherosclerosis.
Semin Thromb Hemost. 1993; 19(2): 144-148.
Doi: 10.1055/s-2007-994018
Web of Science
PubMed
FullText
FullText_MUG
Katzenschlager, R; Weiss, K; Rogatti, W; Peskar, BA; Sinzinger, H
Synergism between PGE1-metabolites(13,14-dihydro-prostaglandin E1, 15-keto prostaglandin E1, 15-keto-13,14-dihydro-prostaglandin E1) and nitric oxide (NO) on platelet aggregation.
Prostaglandins Leukot Essent Fatty Acids. 1992; 45(3):207-210
Doi: 10.1016/0952-3278(92)90114-X
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Pallapies, D; Jirmann, KU; Rademann, J; Simmet, T; Rutowski, J; Dembinska-Kiec, A; Peskar, BA
Effect of prostaglandin E2 and 3-morpholinosydnonimine (SIN-1) on arachidonic acid metabolism in fMLP-stimulated rat neutrophils and on thrombin-induced human platelet aggregation.
Agents Actions. 1992; 36(1-2):77-82
Doi: 10.1007/BF01991232
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Weitere 50 Treffer anzeigen